跳至主要内容
临床试验/EUCTR2017-004698-15-BE
EUCTR2017-004698-15-BE进行中(未招募)1 期

Brain Injury and Ketamine: a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on Therapy Intensity Level and intracranial pressure in acute brain injury patients. - BIKe-study

Z Leuven / KU Leuven0 个研究点目标入组 100 人开始时间: 2020年10月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • * Traumatic brain injury patients
  • * Age = 18 years
  • * Admitted to the ICU
  • * Within 72 hours after admission to the initial hospital:
  • 1)ICP monitor in place (parenchymal probe, ventricular catheter, or both)
  • 2)Requiring sedation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • * Known pregnancy and/or lactation
  • * Imminent or actual brain death upon inclusion
  • * Allergy or intolerance to the study medication
  • * Pre-existing neurocognitive disorders, pre-existing congenital or non-congenital brain dysfunction.
  • * Inability to obtain informed consent
  • * Inclusion in an IMP-RCT of which the PI indicates that co-inclusion specifically in the BIKe study is prohibited.
  • * Therapy restriction code upon inclusion.
  • * Porphyria
  • * Glaucoma

研究者

发起方
Z Leuven / KU Leuven

相似试验